Not a good buy right now for an impatient investor: trend is decisively bearish (SMA_200 > SMA_20 > SMA_5) and momentum is still deteriorating (MACD histogram negative and expanding).
Price (2.385) is below/around near-term support (S1=2.405) after a -3.82% regular-session drop, which increases the odds of a continuation move toward S2 (2.223).
Options positioning is very call-skewed (bullish/speculative), but without a proprietary buy signal and with heavy insider selling, the risk/reward favors staying out until at least a technical base forms.
Intellectia Proprietary Trading Signals: No signal on given stock today (AI Stock Picker: no; SwingMax: no).
Momentum: MACD histogram = -0.0409 (below 0) and negatively expanding → downside momentum is strengthening.
RSI_6 = 11.434 → extremely oversold; a short-term bounce is possible, but oversold alone is not a reliable buy trigger in a strong downtrend.
Levels: Pivot 2.699 (major reclaim level); Resistance R1 2.993 / R2 3.175; Support S1 2.405 (currently being lost) and S2 2.223 (next downside area).
Near-term pattern odds (similar candlesticks): ~flat next day (+0.16%), slightly negative next week (-0.14%), modestly positive next month (+1.95%)—but these are weak edges versus current bearish momentum.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Extremely call-heavy (OI P/C=0.2; Volume P/C=0.07) → traders are positioned bullish/speculative despite the selloff.
Activity: Today’s option volume 4,588, about 113% of 30-day average → elevated attention.
Volatility: IV30 ~112.39 vs historical vol ~66.5 → options are pricing large moves; IV is slightly lower versus recent averages (5D ~115.99; 10D ~118.86), implying elevated but easing fear/speculation.
Takeaway: Options skew is bullish, but it can also reflect high-risk dip-buying; it does not override the bearish tape and insider selling.
Technical Summary
Sell
8
Buy
4
Positive Catalysts
Technical: Extremely oversold RSI can fuel a reflex bounce if selling pressure eases.
Fundamentals (latest reported): 2025/Q3 revenue grew +21.60% YoY and gross margin improved to 37.65% (+13.57% YoY).
Options: Strong call skew suggests some traders are betting on upside/mean reversion.
increases probability of a move toward S2 (2.223).
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 123.287M, +21.60% YoY (growth is a clear positive).
Gross margin: 37.65%, +13.57% YoY (improving unit economics).
Net income: -1.489M, down -111.24% YoY (still loss-making and worsened versus prior year).
EPS: 0, down -100.00% YoY (earnings power not yet showing through despite revenue/margin improvement).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating trend or price target change data was provided in the dataset, so a verified Wall Street pros/cons summary cannot be concluded here.
From the available data only: pros would be accelerating revenue and improving gross margin; cons would be continued losses/EPS deterioration, bearish price trend, and notable insider selling.
Wall Street analysts forecast MVST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MVST is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast MVST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MVST is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 2.390
Low
0
Averages
0
High
0
0
Current: 2.390
Low
0
Averages
0
High
0
H.C. Wainwright
Buy
maintain
$3 -> $6
AI Analysis
2025-08-13
Reason
H.C. Wainwright
Price Target
$3 -> $6
AI Analysis
2025-08-13
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Microvast to $6 from $3 and keeps a Buy rating on the shares. The firm cites strength in the company's operating performance and higher confidence on the completion of Huzhou 3.2 expansion by Q4 for the target increase. This latter will add two gigawatt-hour of annual production capacity to Microvast's support growth expectations in 2026 and beyond, the analyst tells investors in a research note.
